SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $324,000 | +29.6% | 2,843 | -3.1% | 0.14% | +23.3% |
| Q3 2019 | $250,000 | -35.1% | 2,935 | -47.3% | 0.12% | -32.2% |
| Q2 2019 | $385,000 | +58.4% | 5,565 | +67.6% | 0.17% | +64.4% |
| Q1 2019 | $243,000 | -45.5% | 3,320 | -57.9% | 0.10% | -53.2% |
| Q4 2018 | $446,000 | -13.6% | 7,880 | +17.9% | 0.22% | -2.2% |
| Q3 2018 | $516,000 | -2.6% | 6,685 | -16.2% | 0.23% | -9.2% |
| Q2 2018 | $530,000 | +6.0% | 7,980 | -16.5% | 0.25% | -5.3% |
| Q1 2018 | $500,000 | – | 9,555 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |